These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 16950559)

  • 1. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
    Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
    J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic exenteration for recurrent endometrial cancer.
    Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
    Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
    Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
    J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laparoscopy-assisted vaginal pelvic exenteration].
    Ferron G; Querleu D; Martel P; Chopin N; Soulié M
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
    Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
    Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
    Zhang Z; Zang R; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration with curative intent for recurrent uterine malignancies.
    Khoury-Collado F; Einstein MH; Bochner BH; Alektiar KM; Sonoda Y; Abu-Rustum NR; Brown CL; Gardner GJ; Barakat RR; Chi DS
    Gynecol Oncol; 2012 Jan; 124(1):42-7. PubMed ID: 22014627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.
    Kraybill WG; Lopez MJ; Bricker EM
    Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.
    Mourton SM; Chi DS; Sonoda Y; Alektiar KM; Venkatraman ES; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2006 Mar; 100(3):533-6. PubMed ID: 16226800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration for primary and recurrent vulvar cancer.
    Miller B; Morris M; Levenback C; Burke TW; Gershenson DM
    Gynecol Oncol; 1995 Aug; 58(2):202-5. PubMed ID: 7622106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-radical compartmentalized surgery in gynaecological oncology.
    Höckel M
    Eur J Surg Oncol; 2006 Oct; 32(8):859-65. PubMed ID: 16690243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major morbidity after pelvic exenteration: a seven-year experience.
    Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
    Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.